My oped on the JN.1 variant and the 2nd biggest US wave of infections (after Omicron) since the pandemic began
https://t.co/lcjc3meV1n @latimes@latimesopinion#LongCovid
Chemistry to the Clinic, Part 1: The Next Generation of Antibody Drug Conjugates: The #AACRCICR Working Group is hosting this #AACR23 Educational Session (Fri, April 14) featuring Peter S. Dragovich, Marc I. Damelin and Adrian D. Hobson. https://t.co/1MWHwAsffL @marc_drcell
Those readers attending the Resistance to Checkpoint Blockade Immunotherapy session at #SITC22 this morning, might find this article by Lieping Chen of interest https://t.co/DdKBjChBli
A big one.
I've been saying for a decade: "This is biology's century." And we're still not ready.
My editors asked me to explain what that means. It was harder than I expected. I hope you like reading it.
https://t.co/nMyL8crshw
I always tell my students: if you only read paper published in the past five years, the probability that you will have any ground-breaking idea in your lifetime is nearly zero. The odds is probably less than winning a jackpot on a slot machine in Vegas...
Standing ovation after the #ASCO22 Plenary presentation of DESTINY-Breast04 by Dr. Shanu Modi. A beautiful, powerful moment, that will remain in the history of breast oncology.